HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Anew Skintrition Primer Is "Health Food For The Face," The Firm Says

This article was originally published in The Rose Sheet

Executive Summary

Avon has expanded the Anew skin care collection with Skintrition Multi Vitamin Skin Primer to help improve skin clarity and "replenish lost nutrients daily."

You may also be interested in...



Avon Fine-Tuning Beauty Pricing, Product Strategy Following CFT Sales Slip

Avon Products will fine-tune its beauty offerings and adjust pricing strategies in the second half to offset a 2% decline in U.S. cosmetics, fragrances and toiletries sales in the second quarter, North America President Susan Kropf told securities analysts during a conference call July 21.

Avon Will Double Personal Care Sales To $1.5 Bil. By 2005, Jung Predicts

Avon expects to double personal care sales from close to $700 mil. to $1.5 bil. by 2005 as part of the company's continued re-engineering effort and new strategic plan to become "the most relevant, most accessible, most dynamic, most successful beauty company in the world," Chief Operating Officer Andrea Jung told securities analysts March 30.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel